Study Stopped
FDA/IRB approved but hospital administration vetoed the study fearing litigation of a preterm birth though the electrical uterine pacemaker/EI is not the cause.
Electrical Inhibition (EI): A Preliminary Study To Inhibit Preterm Labor And Preterm Birth
EI
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
An electrical-inhibition (EI) uterine pacemaker device similar to an electrical heart pacemaker delivers a weak electrical current to the human uterus during active preterm labor to rapidly and safely inhibit the unwanted premature uterine contractions and possibly a preterm birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2016
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2015
CompletedFirst Posted
Study publicly available on registry
October 6, 2015
CompletedStudy Start
First participant enrolled
February 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2016
CompletedNovember 9, 2017
November 1, 2017
6 months
October 1, 2015
November 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease tocodynamometric monitored preterm uterine contraction frequency
Measure changes in preterm uterine mechanical contraction frequency as assessed by the tocodynamometer. This will be done for the duration of the study.
30 seconds
Secondary Outcomes (1)
Decrease adjunct electrohysterographic monitored preterm uterine contraction electrical activity.
20 seconds
Study Arms (1)
Electrical Inhibition (EI) intervention
EXPERIMENTALElectrical Inhibition (EI) uterine pacemaker is activated only when there is a preterm uterine contraction. The EI uterine pacemaker delivers a 1-15mA (20mA maximum) constant direct current for only 2 seconds only while there is a preterm uterine contraction.
Interventions
constant direct current 1-20mA transvaginal 10 second bursts only when needed
Eligibility Criteria
You may qualify if:
- between 24 to 34 weeks pregnant with a singleton gestation;
- in preterm labor as defined by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics,78 as follows:
- persistent uterine contractions (4 every 20 minutes or 8 every 60 minutes)
- And any one or more of the following:
- Documented cervical change
- \> 1cm cervical dilatation and progressing
- \> 80% cervical effacement
- anticipate a normal spontaneous vaginal delivery (NSVD).
- at least 18 years of age
- signed a written Informed Consent Document
- willing and able to comply with study requirements
You may not qualify if:
- severe preeclampsia
- severe abruption placenta
- rupture of amniotic membranes
- frank chorioamnionitis
- fetal death
- fetal anomaly incompatible with life
- severe fetal growth restriction (EFW \<5%)
- mature fetal lung studies
- maternal cardiac arrhythmias
- a permanent cardiac pacemaker
- a fetal cardiac arrhythmia
- contraindication for tocolysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University Hospital
Manhattan, New York, 10016, United States
Related Publications (2)
Karsdon J, Garfield RE, Shi SQ, Maner W, Saade G. Electrical inhibition of preterm birth: inhibition of uterine contractility in the rabbit and pup births in the rat. Am J Obstet Gynecol. 2005 Dec;193(6):1986-93. doi: 10.1016/j.ajog.2005.05.009.
PMID: 16325601RESULTKarsdon J, El Daouk M, Huang WM, Ashmead GG. Electrical pacemaker as a safe and feasible method for decreasing the uterine contractions of human preterm labor. J Perinat Med. 2012 Nov;40(6):697-700. doi: 10.1515/jpm-2012-0136.
PMID: 23089601RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jeffrey Karsdon, M.D.
New York University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2015
First Posted
October 6, 2015
Study Start
February 9, 2016
Primary Completion
August 15, 2016
Study Completion
August 15, 2016
Last Updated
November 9, 2017
Record last verified: 2017-11